We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Resources to help improve the prevention and diagnosis of bowel cancer.
Population screening programmes: NHS bowel cancer screening (BCSP) programme. The latest pages tagged as BCSP will appear here.
Standards and guidance for health professionals, managers and commissioners working in the NHS bowel cancer screening programme.
Training and continuing professional development (CPD) for people working in the NHS bowel cancer screening programme (BCSP) in England.
Executive summaries from local screening quality assurance (QA) visit reports of bowel cancer screening services, including recommendations.
Guidance on managing people who wish to attend an alternative screening centre to the one the programme invites them to attend.
Find out about the long-term effects some people can have after having COVID-19.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Executive summary of quality assurance (QA) visit to Somerset held on 13 September 2018.
Study protocol for a randomized controlled trial in Regional Anesthesia Techniques for a Planned Randomized Controlled Trial in a Disaster Setting
This document sets out the NHS Bowel Cancer Screening Programme's (BCSP) pathology guidelines for reporting lesions.
This document contains a synopsis of causation occurring in irritable bowel syndrome.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.